Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma 3 Vascular Malformations 1 Hemangioma, Cavernous 1 Hemangioma, Capillary 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

mirdametinib 1 Vincristine 1 Timolol 1 Sirolimus 1 Ointments 1 Mupirocin 1 Everolimus 1 Alpelisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Vascular Malformations × Timolol × Clear all

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡